-
EP2467364
European procedure
Extract from the Register of European Patents
EP About this file: EP2467364
| EP2467364 - NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 20.02.2015 Database last updated on 17.07.2024 | Most recent event Tooltip | 12.10.2018 | Lapse of the patent in a contracting state New state(s): AL | published on 14.11.2018 [2018/46] | Applicant(s) | For all designated states Otsuka Pharmaceutical Co., Ltd. 9, Kanda-Tsukasa-machi 2-chome Chiyoda-ku Tokyo 101-8535 / JP | [2012/26] | Inventor(s) | 01 /
OSHIMA, Kunio c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 02 /
MATSUMURA, Shuuji c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 03 /
YAMABE, Hokuto c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 04 /
ISONO, Naohiro c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 05 /
TAKEMURA, Noriaki c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 06 /
TAIRA, Shinichi c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 07 /
OSHIYAMA, Takashi c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 08 /
MENJO, Yasuhiro c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 09 /
NAGASE, Tsuyoshi c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 10 /
UEDA, Masataka c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 11 /
KOGA, Yasuo c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 12 /
NAKAYAMA, Sunao c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 13 /
TSUJIMAE, Kenji c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 14 /
ONOGAWA, Toshiyuki c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 15 /
TAI, Kuninori c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | 16 /
ITOTANI, Motohiro c/o OTSUKA PHARMACEUTICAL CO. LTD. 1-7-1, Doshomachi Chuo-ku Osaka-shi Osaka 541-0045 / JP | [2012/26] | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2014/16] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE | ||
| Former [2012/26] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastraße 4 81925 München / DE | Application number, filing date | 10751720.3 | 20.08.2010 | WO2010JP64545 | Priority number, date | US20090235973P | 21.08.2009 Original published format: US 235973 P | US20090235981P | 21.08.2009 Original published format: US 235981 P | US20090235983P | 21.08.2009 Original published format: US 235983 P | US20100359686P | 29.06.2010 Original published format: US 359686 P | [2012/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2011021726 | Date: | 24.02.2011 | Language: | EN | [2011/08] | Type: | A2 Application without search report | No.: | EP2467364 | Date: | 27.06.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.02.2011 takes the place of the publication of the European patent application. | [2012/26] | Type: | B1 Patent specification | No.: | EP2467364 | Date: | 16.04.2014 | Language: | EN | [2014/16] | Type: | B9 Corrected patent specification | No.: | EP2467364 | Date: | 18.02.2015 | [2015/08] | Search report(s) | International search report - published on: | EP | 16.06.2011 | Classification | IPC: | C07D243/12, C07D401/12, C07D401/14, C07D403/12, C07D407/14, C07D409/12, C07D409/14, C07D413/14, C07D417/14, C07D491/048, C07D495/04, C07D401/06, C07D403/06, C07D403/14, C07D405/14, C07D413/06, C07D413/12, C07D519/00, C07D471/04, C07D215/227 | [2012/26] | CPC: |
C07D491/048 (EP,US);
C07D471/04 (EP,KR,US);
A61P9/06 (EP);
C07D213/38 (EP,KR,US);
C07D215/227 (EP,US);
C07D243/12 (EP,US);
C07D401/12 (EP,US);
C07D401/14 (EP,US);
C07D403/12 (EP,US);
C07D403/14 (EP,US);
C07D405/14 (EP,US);
C07D409/14 (EP,US);
C07D413/14 (EP,US);
C07D417/12 (EP,US);
C07D417/14 (EP,KR,US);
C07D495/04 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/26] | Extension states | BA | Not yet paid | ME | Not yet paid | RS | Not yet paid | Title | German: | STICKSTOFFHALTIGE VERBINDUNGEN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DARAUS FÜR DIE BEHANLDUNG VON VORHOFFLIMMERN | [2012/26] | English: | NITROGEN-CONTAINING COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF ATRIAL FIBRILLATION | [2012/26] | French: | COMPOSÉ CONTENANT DE L AZOTE ET COMPOSITION PHARMACEUTIQUE | [2012/26] | Entry into regional phase | 30.01.2012 | National basic fee paid | 30.01.2012 | Designation fee(s) paid | 30.01.2012 | Examination fee paid | Examination procedure | 30.01.2012 | Examination requested [2012/26] | 05.10.2012 | Amendment by applicant (claims and/or description) | 17.01.2013 | Despatch of a communication from the examining division (Time limit: M04) | 15.05.2013 | Reply to a communication from the examining division | 18.07.2013 | Communication of intention to grant the patent | 15.10.2013 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.11.2013 | Communication of intention to grant the patent | 27.02.2014 | Fee for grant paid | 27.02.2014 | Fee for publishing/printing paid | Divisional application(s) | EP14153417.2 / EP2727917 | EP14153418.0 / EP2746272 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 17.01.2013 | Opposition(s) | 19.01.2015 | No opposition filed within time limit [2015/13] | Fees paid | Renewal fee | 20.08.2012 | Renewal fee patent year 03 | 23.08.2013 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 16.04.2014 | MK | 16.04.2014 | SM | 16.04.2014 | [2018/46] |
| Former [2018/30] | MK | 16.04.2014 | |
| SM | 16.04.2014 | ||
| Former [2016/22] | SM | 16.04.2014 | Cited in | International search | [X]EP0504695 (HOFFMANN LA ROCHE [CH]) [X] 1-5,10,11,13-15 * page 6, line 32 - page 6, line 33; example 3 * * claims 9-11 *; | [A]WO9640655 (MERCK & CO INC [US], et al) [A] 1-16,18 * the whole document *; | [A]WO0110216 (MERCK & CO INC [US], et al) [A] 1-16,18 * the whole document *; | [X]WO2007026959 (OTSUKA PHARMA CO LTD [JP], et al) [X] 18 * page 408 - page 408; examples 1031-1032 * * page 411 - page 411; examples 1051-1052 *; | [XP]WO2009104819 (OTSUKA PHARMA CO LTD [JP], et al) [XP] 18 * page 70 - page 71; example 1 ** page 241 - page 241; example 685 * | by applicant | - THE JOURNAL OF AMERICAN MEDICAL ASSOCIATION, (2001), vol. 285, pages 2370 - 2375 | - CIRCULATION, (2006), vol. 114, pages 119 - 123 | - AM. J. CARDIOL., (1993), vol. 72, pages B44 - B49 | - NATURE REVIEWS DRUG DISCOVERY, (2005), vol. 4, pages 899 - 910 | - NATURE REVIEWS DRUG DISCOVERY, (2006), vol. 5, pages 1034 - 49 | - TRENDS PHANNACOL. SOC., (2001), vol. 22, pages 240 - 246 | - CRIC. RES., (1993), vol. 73, pages 1061 - 1076 | - J. PHYSIOL., (1996), vol. 491, pages 31 - 50 | - CRIC. RES., (1997), vol. 80, pages 572 - 579 | - NATURE, (1995), vol. 374, pages 135 - 141 |